- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Pancreatic cancer
- Meeting Date: March 2019
- Public Summary Document (PSD) March 2019 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2019 PBAC Meeting - Word
Nanoparticle albumin-bound paclitaxel – March 2019
Paclitaxel, Nanoparticle Albumin-Bound: Powder for I.V. injection containing 250 mg paclitaxel; Abraxane®
Last updated
5 July 2019